Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harvard Bioscience (HBIO)
NASDAQ:HBIO
Holding HBIO?
Track your performance easily
HBIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.99 - $5.56
Previous Close$2.11
Volume322.35K
Average Volume (3M)153.94K
Market Cap
$91.59M
Enterprise Value$131.59M
Total Cash (Recent Filing)$4.57M
Total Debt (Recent Filing)$44.56M
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Mar 06, 2025EPS Estimate
$0.05Last Dividend Ex-Date
Nov 04, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)-0.33
Shares Outstanding43,616,621
10 Day Avg. Volume153,681
30 Day Avg. Volume153,939
Standard Deviation0.15
R-Squared0.20
Alpha-0.00941
Financial Highlights & Ratios
Price to Book (P/B)1.41
Price to Sales (P/S)0.94
Price to Cash Flow (P/CF)-27.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.39
Enterprise Value/Gross Profit1.99
Enterprise Value/Ebitda-29.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Harvard Bioscience News
PremiumCompany Announcements
Harvard Bioscience Reveals Q3 2024 Financial Results
PremiumPre-Earnings
Is HBIO a Buy, Before Earnings?
Ownership Overview
10.81% Insiders
19.28% Mutual Funds
37.47% Other Institutional Investors
22.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HBIO FAQ
What was Harvard Bioscience’s price range in the past 12 months?
Harvard Bioscience lowest stock price was $1.99 and its highest was $5.56 in the past 12 months.
What is Harvard Bioscience’s market cap?
Currently, no data Available
When is Harvard Bioscience’s upcoming earnings report date?
Harvard Bioscience’s upcoming earnings report date is Mar 06, 2025 which is in 74 days.
How were Harvard Bioscience’s earnings last quarter?
Harvard Bioscience released its earnings results on Nov 07, 2024. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of $0.015 by -$0.035.
Is Harvard Bioscience overvalued?
According to Wall Street analysts Harvard Bioscience’s price is currently Overvalued.
Does Harvard Bioscience pay dividends?
Harvard Bioscience pays a Notavailable dividend of $1.345 which represents an annual dividend yield of N/A. See more information on Harvard Bioscience dividends here
What is Harvard Bioscience’s EPS estimate?
Harvard Bioscience’s EPS estimate is $0.05.
How many shares outstanding does Harvard Bioscience have?
Harvard Bioscience has 43,616,620 shares outstanding.
What happened to Harvard Bioscience’s price movement after its last earnings report?
Harvard Bioscience reported an EPS of -$0.02 in its last earnings report, missing expectations of $0.015. Following the earnings report the stock price went down -15.248%.
Which hedge fund is a major shareholder of Harvard Bioscience?
Among the largest hedge funds holding Harvard Bioscience’s share is Harvey Partners LLC. It holds Harvard Bioscience’s shares valued at 7M.
---
Harvard Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Increased
By 152.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.80%
12-Months-Change
Fundamentals
Return on Equity
-20.40%
Trailing 12-Months
Asset Growth
-6.08%
Trailing 12-Months
Company Description
Harvard Bioscience
Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
---
HBIO Company Deck
---
HBIO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reveals a company in transition, dealing with significant revenue declines and challenges in the APAC region, particularly China. However, there are positive signs with stabilization in the Americas and Europe, successful cost reductions, and promising new product introductions that could drive future growth.Read More>---
HBIO Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering HBIO
1 Year
1 Year Success Rate
5/9 ratings generated profit
1 Year Average Return
+7.10%
reiterated a buy rating 5 months ago
Copying Bruce Jackson's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +7.10% per trade.
---